Valuation Artivion, Inc. Deutsche Boerse AG
Stocks
CYL
US2289031005
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.00 EUR | +4.76% |
|
+5.77% | -43.66% |
| 29/06 | Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Defensive Index | CI |
| 29/06 | Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Value Benchmark Index | CI |
Company Valuation: Artivion, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 800.4 | 488.8 | 733.9 | 1,198 | 2,161 | 1,216 | - | - |
| Change | - | -38.93% | 50.16% | 63.29% | 80.29% | -43.7% | - | - |
| Enterprise Value (EV) | 1,058 | 761.4 | 733.9 | 1,198 | 2,161 | 1,216 | 1,216 | 1,216 |
| Change | - | -28.05% | -3.6% | 63.29% | 80.29% | -43.7% | 0% | 0% |
| P/E | -53.6x | -25.3x | -23.8x | -89.3x | 217x | 299x | 61.5x | 31.7x |
| PBR | 2.7x | 1.72x | - | - | - | - | - | - |
| PEG | - | -1x | -0.4x | 1.6x | -1x | -5x | 0x | 0.3x |
| Capitalization / Revenue | 2.68x | 1.56x | 2.07x | 3.08x | 4.9x | 2.5x | 2.25x | 2.02x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.5x | 2.25x | 2.02x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 12.9x | 10.5x | 8.71x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 37.3x | 20.9x | 15.1x |
| EV / FCF | - | - | - | - | - | -62.7x | 62.7x | - |
| FCF Yield | - | - | - | - | - | -1.59% | 1.59% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.38 | -0.48 | -0.75 | -0.32 | 0.21 | 0.0838 | 0.4075 | 0.79 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 298.8 | 313.8 | 354 | 388.5 | 441.3 | 486.2 | 539.8 | 600.8 |
| EBITDA 1 | 44.28 | 41.56 | 53.82 | 71.26 | 89.6 | 94.3 | 115.5 | 139.7 |
| EBIT 1 | 8.117 | 6.201 | 5.742 | 38.87 | 33.74 | 32.57 | 58.29 | 80.33 |
| Net income 1 | -14.83 | -19.19 | -30.69 | -13.36 | 9.768 | 4.4 | 22.59 | 39.24 |
| Net Debt | 257.8 | 272.6 | - | - | - | - | - | - |
| Reference price 2 | 20.35 | 12.12 | 17.88 | 28.59 | 45.61 | 25.06 | 25.06 | 25.06 |
| Nbr of stocks (in thousands) | 39,330 | 40,329 | 41,049 | 41,920 | 47,375 | 48,543 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 24/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.38x | 3.95x | 15.2x | 2.57% | 18TCr | ||
| 18.88x | 3.31x | 11.62x | 3.57% | 11TCr | ||
| 17.13x | 0.19x | 12.1x | 0.77% | 5.99TCr | ||
| 31.81x | 7.73x | 20.21x | 1.26% | 5.2TCr | ||
| 39.41x | 3.13x | 10.67x | 2.43% | 4.36TCr | ||
| 38.15x | 1.39x | 12.22x | 0.26% | 3.36TCr | ||
| 31.31x | 5.58x | 17.8x | -.--% | 2.96TCr | ||
| 42.57x | 7.44x | 26.86x | 0.24% | 2.53TCr | ||
| 23.96x | 3.5x | 12.59x | 1.21% | 2.12TCr | ||
| Average | 30.07x | 4.02x | 15.47x | 1.37% | 6.08TCr | |
| Weighted average by Cap. | 27.43x | 3.78x | 14.67x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AORT Stock
- CYL Stock
- Valuation Artivion, Inc.
Select your edition
All financial news and data tailored to specific country editions
















